Lys Therapeutics
Developer of biotherapies designed to treat patients suffering from neurovascular or neurodegenerative disorders. The company's drugs are based on the monoclonal antibody, one protease called tissue p...
Valuation
$0
Share Price
N/A
Total Raised
$5.5M
Last Round
N/A